Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-07-19

Clinical Trial Update: To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity. [NA]

View source ↗

Summary

This University of Pisa clinical trial investigates whether GLP-1 influences cognitive function, brain glucose metabolism, and neuroplasticity, across condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: University of Pisa | Conditions: Glucose Metabolism Disorders, Obesity | NA | Status: COMPLETED